multiple unexplained nose bleeds/ Reoccurred 2 months later; Intense headaches/  Reoccurred 2 months later; Intense headaches; multiple unexplained nose bleeds; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 24May2021 12:00 (Lot number: EW0175) at the age of 51 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (product = COVID 19 , brand=Pfizer, lot number = EW0153, administration time = 14:00, dose number=1, vaccine location = Left arm, Route of administration: Intramuscular, Exp Jul2021), administration date: 08Apr2021, when the patient was 51 years old, for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset May2021, outcome "recovered" (2021), described as "Intense headaches"; EPISTAXIS (non-serious) with onset May2021, outcome "recovered" (2021), described as "multiple unexplained nose bleeds"; EPISTAXIS (non-serious) with onset Oct2021, outcome "not recovered", described as "multiple unexplained nose bleeds/ Reoccurred 2 months later"; HEADACHE (non-serious) with onset Oct2021, outcome "not recovered", described as "Intense headaches/Reoccurred 2 months later". The events "intense headaches", "multiple unexplained nose bleeds", "multiple unexplained nose bleeds/ reoccurred 2 months later" and "intense headaches/ reoccurred 2 months later" were evaluated at the physician office visit. Therapeutic measures were taken as a result of headache, headache. Therapeutic measures were not taken as a result of epistaxis, epistaxis.  Additional information: reported event: Intense headaches in the days following the last injection (not the first), which lasted for a few weeks on and off. Patient also had multiple unexplained nose bleeds when was having a headache, usually in the morning. The headaches interfered with his work, treated with Tylenol and often rested in a dark room (at the time he was working from home), they would go away after 24-36 hours. The headaches and nosebleeds eventually subsided but then reoccurred 2 months later when returned to my office, coincidently there were a few people that reported feeling ill but nobody tested positive for COVID (all vaccinated). Patient only bring this forward as a side effect because can count on one hand the number of times patient have had a headache. Patient also do not have allergies or live in a dry climate, and cannot explain the nosebleeds. No history of headaches or nose bleeds. Headaches are treated with Excedrin. Nose bleeds go away same day. Headaches remain for days. Both come and go randomly. Both lessened in frequency into September but resurfaced in October. Facility where the most recent COVID-19 vaccine was administered was pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive other medications within 2 weeks of vaccination. The adverse event result in doctor or other healthcare professional office/clinic visit. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, has the patient had not been tested for COVID-19. The patient receive any other vaccines within four weeks prior to the COVID vaccine was none. The specific relevant test for thromboembolic events with thrombocytopenia was none. Relevant tests was none. The event require OTC medication the initiation of new medication/other treatment/procedure.  Follow-up attempts are completed. No further information is expected.